RXT vs TMO · rev $2.74B vs P/E 24, rev $44.56B
Rackspace Technology Inc (RXT) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Rackspace Technology Inc (RXT) is a software - infrastructure company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported RXT revenue for 2024-12-31 was $2.74B. Net income was -$858.2M. Revenue was down 7.4% from 2023-12-31 to 2024-12-31. RXT currently screens at market cap $330.0M.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
RXT currently screens at market cap $330.0M. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the RXT and TMO stock pages for the full models.
Not investment advice.